| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2005-01-31 |
5 |
S |
$5.78 |
$8,849 |
D/D |
(1,531) |
46,511 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2005-06-30 |
5 |
S |
$4.45 |
$1,876 |
D/D |
(422) |
50,933 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-04-02 |
4 |
S |
$13.46 |
$2,720,111 |
D/D |
(202,090) |
189,486 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-04-29 |
4 |
S |
$24.92 |
$14,952,360 |
D/D |
(600,000) |
486,536 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-29 |
4 |
S |
$51.01 |
$20,405,120 |
D/D |
(400,000) |
379,246 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-30 |
4 |
S |
$54.71 |
$8,473,790 |
D/D |
(154,887) |
224,359 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-04-02 |
4 |
OE |
$2.21 |
$491,806 |
D/D |
151,157 |
276,690 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-04-29 |
4 |
OE |
$4.41 |
$3,543,959 |
D/D |
542,928 |
544,764 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-29 |
4 |
OE |
$4.41 |
$2,216,615 |
D/D |
270,625 |
525,616 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-03 |
4 |
OE |
$4.41 |
$86,975 |
D/D |
19,000 |
296,301 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
308,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
301,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-05-25 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
282,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-06-27 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
271,174 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-25 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
229,666 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-12 |
4 |
OE |
$0.45 |
$3,876 |
D/D |
8,613 |
8,613 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
OE |
$0.45 |
$1,081 |
D/D |
2,402 |
2,402 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-22 |
4 |
OE |
$0.45 |
$17,021 |
D/D |
37,825 |
37,825 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
OE |
$0.45 |
$15,436 |
D/D |
24,486 |
24,486 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-27 |
4 |
OE |
$0.65 |
$19,222 |
D/D |
29,573 |
29,573 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
OE |
$0.65 |
$660 |
D/D |
1,016 |
1,016 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-28 |
4 |
OE |
$12.74 |
$948,378 |
I/I |
74,441 |
2,675,421 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-08 |
4 |
OE |
$7.55 |
$100,000 |
D/D |
13,245 |
109,245 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2008-05-21 |
5 |
GD |
$5.06 |
$32,890 |
D/D |
6,500 |
381,642 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2008-12-31 |
5 |
GD |
$4.58 |
$4,580 |
D/D |
1,000 |
377,546 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
